Abbott Laboratories (ABT)
| Previous close | 105.27 |
| Open | 105.98 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 800 |
| Day's range | 105.41 - 107.77 |
| 52-week range | 89.67 - 121.64 |
| Volume | |
| Avg. volume | 5,865,919 |
| Market cap | 185.248B |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | 33.26 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.20 (2.09%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
- Insider Monkey
Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here. The US stock market started 2024 optimistically. In the first quarter, the fund returned 8.29% (gross) and 8.09% (net) compared to 11.41% for the Russell 1000 Growth Index and […]
- Simply Wall St.
Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts
Abbott Laboratories ( NYSE:ABT ) shareholders are probably feeling a little disappointed, since its shares fell 5.5% to...
- Insider Monkey
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript April 17, 2024 Abbott Laboratories isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Robert Ford – Chairman and Chief Executive Officer: Phil Boudreau – Senior Vice President, Finance and Chief Financial Officer: Bob […]
